---
figid: PMC10708146__molecules-28-07813-g002
figtitle: GSDMD-mediated pyroptosis in DCM
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10708146
filename: molecules-28-07813-g002.jpg
figlink: /pmc/articles/PMC10708146/figure/F2
number: F2
caption: GSDMD-mediated pyroptosis in DCM. Metabolic disorders are crucial to the
  pathogenesis of DCM. Hyperglycemia and hyperlipidemia affect mitochondrial dysfunction
  to release mtDNA and mtROS, activate the NFκB signaling pathway, promote the transcription
  of non-coding RNAs and inflammasome assembly (NLRP3 or AIM2), and activate caspase-1
  cleavage of GSDMD to produce an N-terminal GSDMD fragment, which mediates the formation
  of membrane pores, promoting inflammatory cytokines secretion
papertitle: 'Gasdermin D-Mediated Pyroptosis in Diabetic Cardiomyopathy: Molecular
  Mechanisms and Pharmacological Implications'
reftext: Zhou Liu, et al. Molecules. 2023 Dec;28(23).
year: '2023'
doi: 10.3390/molecules28237813
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI
keywords: pyroptosis | Gasdermin D | diabetic cardiomyopathy | heart | inflammasomes
automl_pathway: 0.9302663
figid_alias: PMC10708146__F2
figtype: Figure
redirect_from: /figures/PMC10708146__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10708146__molecules-28-07813-g002.html
  '@type': Dataset
  description: GSDMD-mediated pyroptosis in DCM. Metabolic disorders are crucial to
    the pathogenesis of DCM. Hyperglycemia and hyperlipidemia affect mitochondrial
    dysfunction to release mtDNA and mtROS, activate the NFκB signaling pathway, promote
    the transcription of non-coding RNAs and inflammasome assembly (NLRP3 or AIM2),
    and activate caspase-1 cleavage of GSDMD to produce an N-terminal GSDMD fragment,
    which mediates the formation of membrane pores, promoting inflammatory cytokines
    secretion
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADM
  - YME1L1
  - TLR4
  - MYD88
  - NFKB1
  - IRF3
  - METTL14
  - PAWR
  - F2RL3
  - PWAR4
  - XK
  - NLRP1
  - CGAS
  - STING1
  - CTSA
  - CTSB
  - CTSC
  - CTSD
  - CTSE
  - CTSF
  - CTSG
  - CTSH
  - CTSK
  - CTSL
  - CTSO
  - CTSS
  - CTSV
  - CTSW
  - CTSZ
  - AIM2
  - MED12
  - COL9A1
  - COL9A2
  - COL9A3
  - COMP
  - SCN8A
  - CCNC
  - CDK8
  - CDK19
  - MED1
  - MED29
  - MED27
  - MED4
  - MED24
  - MED6
  - MED7
  - MED8
  - MED9
  - MED10
  - MED11
  - MED12L
  - MED13
  - MED13L
  - MED14
  - MED15
  - MED16
  - MED17
  - MED18
  - MED19
  - MED20
  - MED21
  - MED22
  - MED23
  - MED25
  - MED26
  - MED28
  - MED30
  - MED31
  - STS
  - PYCARD
  - NLRP3
  - SIRT3
  - GSDMD
  - MIAT
  - IL1A
  - IL1B
  - IL18
  - Thrombin
  - NAC
  - AGE
  - DHI
  - cardiomyopathy
  - Diabetes mellitus
---
